Literature DB >> 20610494

Correlation of self-assessed fatigue and alertness in multiple sclerosis.

Nicholetta Weinges-Evers1, Alexander U Brandt, Markus Bock, Caspar F Pfueller, Jan Dörr, Judith Bellmann-Strobl, Peter Scherer, Carsten Urbanek, Claudia Boers, Stephanie Ohlraun, Frauke Zipp, Friedemann Paul.   

Abstract

BACKGROUND: Fatigue is the most common symptom in multiple sclerosis patients, but is difficult to measure; quantification thus relies on self-assessed questionnaires.
OBJECTIVE: To evaluate a battery of neuropsychological tests regarding their capacity to objectify self-reported fatigue.
METHODS: We assessed the correlation between age, gender, education, Kurtzke's Expanded Disability Status Scale, depression, fatigue and neuropsychological testing using a cross-sectional approach in 110 multiple sclerosis patients. Fatigue was measured with the Fatigue Severity Scale. Cognition was measured using a series of neuropsychological tests including three subtests of the Test of Attentional Performance, the Brief Repeatable Battery of Neuropsychological Tests and the Faces Symbol Test.
RESULTS: According to the Fatigue Severity Scale 51.4% of the cohort were fatigued (scores > or =4). Age, education and depression showed a significant correlation with the Fatigue Severity Scale. Only 5.5% of the cohort exhibited cognitive impairment in the Brief Repeatable Battery of Neuropsychological Tests scores. After correction for age, education, Expanded Disability Status Scale and depression, Fatigue Severity Scale scores were an independent predictor of performance in the alertness subtest of the Test of Attentional Performance (standardized coefficient beta = 0.298, p = 0.014).
CONCLUSION: The alertness subtest of the Test of Attentional Performance may offer an objective method of evaluating self-reported fatigue, and may therefore - in addition to the Fatigue Severity Scale - be a suitable tool for the assessment of multiple sclerosis patients complaining of fatigue.

Entities:  

Mesh:

Year:  2010        PMID: 20610494     DOI: 10.1177/1352458510374202

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  23 in total

1.  [Current immunotherapy of multiple sclerosis].

Authors:  F Paul; K Ruprecht
Journal:  Nervenarzt       Date:  2015-08       Impact factor: 1.214

2.  Dynamics of saccade parameters in multiple sclerosis patients with fatigue.

Authors:  Carsten Finke; Luisa Maria Pech; Carina Sömmer; Jeremias Schlichting; Sarah Stricker; Matthias Endres; Florian Ostendorf; Christoph J Ploner; Alexander U Brandt; Friedemann Paul
Journal:  J Neurol       Date:  2012-06-19       Impact factor: 4.849

3.  Structural correlates for fatigue in early relapsing remitting multiple sclerosis.

Authors:  Janine Wilting; Hans O Rolfsnes; Hilga Zimmermann; Marion Behrens; Vinzenz Fleischer; Frauke Zipp; Adriane Gröger
Journal:  Eur Radiol       Date:  2015-05-31       Impact factor: 5.315

4.  Electrophysiological and behavioral effects of frontal transcranial direct current stimulation on cognitive fatigue in multiple sclerosis.

Authors:  Marina Fiene; Katharina S Rufener; Maria Kuehne; Mike Matzke; Hans-Jochen Heinze; Tino Zaehle
Journal:  J Neurol       Date:  2018-01-22       Impact factor: 4.849

Review 5.  [Therapy of fatigue in multiple sclerosis : A treatment algorithm].

Authors:  C Veauthier; F Paul
Journal:  Nervenarzt       Date:  2016-12       Impact factor: 1.214

6.  Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?

Authors:  Anja Mähler; Silvia Mandel; Mario Lorenz; Urs Ruegg; Erich E Wanker; Michael Boschmann; Friedemann Paul
Journal:  EPMA J       Date:  2013-02-18       Impact factor: 6.543

7.  Exercise in multiple sclerosis -- an integral component of disease management.

Authors:  Andrea Döring; Caspar F Pfueller; Friedemann Paul; Jan Dörr
Journal:  EPMA J       Date:  2011-12-24       Impact factor: 6.543

8.  Sleep Disorders Reduce Health-Related Quality of Life in Multiple Sclerosis (Nottingham Health Profile Data in Patients with Multiple Sclerosis).

Authors:  Christian Veauthier; Gunnar Gaede; Helena Radbruch; Klaus-Dieter Wernecke; Friedemann Paul
Journal:  Int J Mol Sci       Date:  2015-07-21       Impact factor: 5.923

9.  Can we prevent or treat multiple sclerosis by individualised vitamin D supply?

Authors:  Jan Dörr; Andrea Döring; Friedemann Paul
Journal:  EPMA J       Date:  2013-01-29       Impact factor: 6.543

10.  The transition from first-line to second-line therapy in multiple sclerosis.

Authors:  Jan Dörr; Friedemann Paul
Journal:  Curr Treat Options Neurol       Date:  2015-06       Impact factor: 3.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.